The Valley Desk

NCT03013543 · Interventional trial

Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity

Overall registry status Completed

Phase 2

Conditions Genetic Obesity, Obesity, Obesity Due to Melanocortin 4 Receptor Deficiency

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov